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Abstract
Besides eradication of chronic middle ear disease, the reconstruction
of the sound conduction apparatus is a major goal of modern ear
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microsurgery.Thematerialofchoiceincasesofpartialossicularreplace-
ment prosthesis is the autogenous ossicle. In the event of more exten-
sivedestructionoftheossicularchaindiversealloplasticmaterials,e.g. 1 Universitäts-HNO-Klinik,Köln,
Germany metals,ceramics,plasticsorcompositsareusedfortotalreconstruction.
Their specialised role in conducting sound energy within a half-open
implant bed sets high demands on the biocompatibility as well as the
acoustic-mechanicpropertiesoftheprosthesis.Recently,sophisticated
titanium middle ear implants allowing individual adaptation to anatom-
ical variations are widely used for this procedure. However, despite
moderndevelopments,hearing restorationwith passive implants often
facesits limitationsdue to tubal-middle-eardysfunction.Here,implant-
able hearing aids, successfully used in cases of sensorineural hearing
loss, offer a promising alternative. This article reviews the actual state
of affairs of passive and active middle ear implants.
Keywords: middle ear, implantable hearing aids, tympanoplasty,
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1 Introduction
Today, modern surgical techniques almost always allow
thecureofoncelife-threateninginflammatory processes
of the middle ear. In addition, restoring of a normal
hearing ear is the ultimate objective of tympanoplasty
[1], [2], [3], [4]. In a society based upon communication,
socialhearingis,afterall,essential.Unfortunately, inthe
half a century since the introduction of “tympanoplasty”,
the audiological results have all too often been unsatis-
factory [5]. Research and modern developments in
passivemiddleeartransplants[6],[7],[8]cannotobscure
the fact that factors independent of implants are just as
decisiveforpostoperativehearingresults.Inmanycases,
restoration of a normal tubal-middle ear function cannot
be influencedsurgically[9], [10], and which is necessary
fortheaerationandpropervibrationofthereconstructed
middle ear structures. As well as further biological para-
meters(Table1),surgeons’ownexperience[11],theuse
of a staged reconstructive procedure [5], as well as the
condition of the ossicles (e.g. an existing manubrium of
malleus) [10] are all relevant factors for the prognosis
forhearingrecovery.Ifaudiologicalrehabilitationfollowing
passive tympanoplasty is not satisfactory, conventional
airconductionhearingdevicesareanalternativetherapy.
Inparticularinmixedhearinglosspatientswiththeirhigh
air conduction thresholds, and problems of the auditory
canalthecapacityofconventionalhearingaidsisseverely
limited. Modern approaches via bone conduction might
be one solution: for the past 25 years, partially im-plant-
able bone-anchored hearing aids such as the BAHA
®
(BoneAnchoredHearingAid,CochlearCompany,Sydney,
Australia) have been used for the rehabilitation of con-
ductive and combined hearing loss [8], [12], [13]. A fur-
ther development in product technology in recent years
has led to a broader range of indications [14]. Sounds
are transmitted directly onto the cranial bone via an
easilymaintainedtranscutaneousconnectionscrew,and
reach the cochlea by way of bone conduction. An even
more targeted stimulation of the inner ear has recently
beenmadepossiblebyactivemiddleearimplants,where
a variety of different connecting possibilities for implant-
able hearing aids are described.
2 Passive middle ear implants
A characteristic feature of passive middle ear implants
is the non-reinforced transmission of incident sound
waves. Depending upon the defects to be reconstructed,
the classification of tympanoplasty types formulated by
Wullstein is used [1]. Figure 1 reproduces schematically
the principal forms of passive middle ear implants. Here
there is a differentiation made between the presence or
the defectiveness of the manubrium of malleus and/or
the stapes superstructure with continuingly preserved
stapesfootplate.Inthecaseoftheclassictympanoplasty
type III, a distinction is made between the partial, short
reconstructionform(PORP-Reconstruction;“PartialOssi-
cularReplacementProsthesis”)mountedupontheintact
stapes, and a total, long reconstruction with no stapes
superstructure (TORP-Reconstruction; “Total Ossicular
Replacement Prosthesis”). On the lateral side, i.e. the
“receiving end”, the moulding is designed on an existing
manubrium of malleus (L-form) or on the connection dir-
ectly at the ear drum.
1/19 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2009, Vol. 8, ISSN 1865-1011
Review Article OPEN ACCESSTable 1: Implant-independent factors of postoperative hearing
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Figure 1: The classic reconstruction forms of tympanoplasty type III differentiate between either the presence or absence of a
stapes superstructure (short = partial or long = total prosthesis), and also the manubrium of malleus (L or T shape).
As well as the appropriate form, the prosthesis material
is crucial for the ultimate success of the procedure: if
thereisintolerance,nosatisfactoryacousticfunctioncan
be expected.
From a biological point of view, there can be no match
for the body’s own material. However, the body’s own
ossicle residue is not always available for the required
reconstruction form, or suitable for a long columella in
the case of a missing stapes superstructure. Therefore
in the early years of tympanoplasty, allogeneic(homolog-
ous)ossicles,usuallyafterCialitorformalinconservation,
were referred on in great measure. In Germany at least,
strict legal regulations have managed to do away with
this material which for decades has been effective. In-
stead, diverse alloplastic (exogenic) implant materials
experimentalincellculturehavebeentestedasalternat-
ives, both clinically and in animal studies [6], [7]. An
overview of alloplastic materials examined for ossicular
chain replacement can be found in Table 2.
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2.1.1 Clinical, biological demands
Foryearsthesearchhasbeenonforanim-plantmaterial
which is free of health risks, is cost-effectively available
in a variety of forms, and which can be individually adap-
ted intraoperatively without major additional effort. If
these implants are tissue-friendly, they can be regarded
as biomaterials. However, the special situation of the
middle ear must be taken into account. In the case of
chronicotitismedia,itiscontaminatedorevencompletely
infected by bacteria. The implants used must therefore
not only be biocompatible, but also middle ear compat-
ible, which should qualify them as bio-stable and non-
degradable in this semi-open implant bed [6], [7], [15].
For implants to be newly developed, sufficient testing in
cell culture and in animal studies is required [16], where
not the muscle, but rather the aerated middle ear with
its thin coat of mucous membrane must be selected as
analogousimplantbed.Becauseofthissurroundingarea,
middle ear implants should be epithelised quickly and
demonstrate good wettability. In view of the increase in
imaging methods, implants should not only be MRT-
compatibleinordertoavoiddamagetotheinnerear[17],
but also free from any tendency to artifact in radiology.
A simple and standardised connection to existing ossicle
residue, which is also easily detached in revision opera-
tions, is required. Furthermore, cost-effective and stand-
ardisedimplantsolutionsshouldbe soughtin which cost
calculations must also be included.
There can be no answer to the question of the ideal
prosthesis, however, as it is not the material, but rather
the destructive power of the inflamed middle ear which
decides the future of the prosthesis (always provided
there is a tissue-friendly substance). Bioactive materials
suchasossicles,bones,cartilage,butalsobiodegradable
ceramics such as glass ceramics or hydroxyapatite, are
dissolved in chronically inflamed tissue layers, whereas
bio-inertmaterialssuchasmetalsorthealuminiumoxide
ceramicsremainintact,butareextruded(andthusappear
to the patient and surgeon to be unsuitable). The non-
irritant, in flammation-free middle ear tolerates almost
every material, provided it is a non-toxic and tissue-
friendly substance.Even teeth (dentin) [18], [19], [20] or
toe nails (keratin) [21] have been successfully used. The
search for the ideal prosthesis from a biological point of
view invariably develops into a healing condition of the
chronic middle ear in flammation: only a non-irritant, in-
flammationfreemiddleearmucosawithunhinderedtube
function suggests an efficient function of the ossicular
replacement due to the air level in the tympanic cavity.
If there is an ongoing in flammation, no satisfactory
prosthetic function will be arrived at.
2.1.2 Acoustic and mechanical demands
Prostheses for the reconstruction of the ossicular chain
must exhibit material properties and forms, as well as
biological middle ear compatibility, which qualify them
for sound transmission. As the publications on clinical
audiological results with a variety of materials and by in-
dividual surgeons have no great level of evidence, and
generally allow no more than a limited statement on
acoustic transfer properties [5], in recent years, with the
availability of modern measuring techniques (Laser
Doppler Vibrometry=LDV), there has been a shift from
purely empirical to theoretical and experimental implant
development[22],[23],[24].Thedecisiveacousticfactor
clinically usually only recognisable with revision surgery
is stable healing and thus the quality of the connection
of the implant between the residue of the conductive
hearing apparatus [5]. As well as the design of the pros-
thesis, the mass and rigidity of the material are decisive
factors for acoustic transmission quality [8]. Through
analyses and impedance calculations on the middle ear
model, it is demonstrated that passive implants should
have a higher stiffness than the sum of the impedance
ofstapesandinnerear[25].Inmodelanalyses,theinflu-
ence of prosthesis stiffness could beensuredon conduc-
tion at higher frequencies [26]. With the help of the LDV,
which has now become the standard instrument of
measurement in middle ear laboratories world-wide, it
was possible for a number of research groups to
demonstrate experimentally in the temporal bone model
that a critical prosthesis mass of 15 mg should not be
exceeded in order to allow a loss-free transfer of high
frequencies in particular [8], [27]. An overview of the
mechanical and acoustic demands on passive middle
ear transplants is shown in Table 3.
2.2 Materials for passive implants
2.2.1 Autogenous transplants
Inprincipal,endogenousossicles,boneandcartilageare
available here. As a relatively low impedance material,
cartilage is, from an acoustic point of view, only to be
used for reconstruction of the tympanic membrane, and
not for procedures in the ossicular chain, since due to
resorption processes with consecutive chondromalacia
[28], dimensional stability decreases. Autogenous ossi-
cular residue, incus body or malleus head, on the other
hand, are regarded as the golden standard for chain re-
construction [29], if an attached cholesteatom matrix,
an ostitis or extensive destruction do not suggest that
they are unsuitable for reuse [30]. The bone of the fitted
ossicle prosthesis is replaced over the years mainly by
osteoneogenesis [31]. Here the revascularisation takes
place via the Havers canals [32].
In cases of inflammatory granulationtissue, on the other
hand, there is a degradation of the adjoining bone [33],
[34]. One fundamental risk associated with this material
is the bony growth on surroundingstructuressuch as the
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auditory canal, the promontorium or the bony canal of
the facial nerve with resultant loss of transmission. A
further disadvantage is the limited size of the ossicle,
which means that they often appear to be too short for
bridging longer distances, in the case, e.g., of petrous
bone fracture or with no stapes superstructure as a long
columella. Due to their porous structure with higher risk
ofresorptionandtendencytobonygrowthonsurrounding
middle ear structure, the alternative to prostheses made
fromautogenouscorticalbonehasnotprovedsuccessful
[35], [36].
2.2.2 Allogeneic transplants
Ifnoendogenousossicleswereavailable,fromthe1960s
to the 1980s “homogenous corpse” ossicles were the
most frequently used prostheses [37], [38], [39]. How-
ever, the integration of transplants conserved in formal-
dehyde and cialit in the organism is evaluated slightly
less favourably in comparison with autogenous ossicles
[32]. The risk of infection by HIV and the typical germs
connected with ear infections as a result of this conser-
vation was negligible [40], the postulated prions of
Creutzfeldt Jacob Disease (CJD) were, however, not con-
trollable even by means of an autoclave. For this reason
allogeneic ossicles in Germany can practically no longer
be used. A reappraisal of the current state of research in
the literature [41] was not able to verify any cases of in-
fection with HIV or CJD following an ossicle transplant. In
the two otological cases with CJD infection, in the first
dura mater, and in the second pericardium were used as
replacements for the tympanic membrane. In some
countries,therefore,allogeneicossiclesmaystillbeused,
based on selection criteria for the donor and special
processing methods [42].
Implants made from dentin [18], [19], [20] which due to
their mechanical stability were extremely suitable as
ossicleprostheses,canbeautoclaved,butaresidualrisk
of CJD still remains.
2.2.3 Alloplastic implants
Depending on the body’s reaction, alloplastic materials
can basically be divided into 3 implant groups [15], [35]:
1. bio-inert
2. bio-tolerant
3. bio-active
2.2.3.1 Bio-inert materials
Bio-inert materials do not react with the body; they are
only covered by a thin layer of mucous membrane, and
are not degraded by inflammatory processes.
Prostheses made from stainless steel or tantalum were
popular up into the 1980s as a versatile and cost-effect-
ive material in reconstructive middle ear surgery. Tan-
talum showed a non-irritable coating of mucous in the
middle ear and the vestibulum three to six months after
the implant [43]. Stainless steel could also be used with
goodfunctionalresults[44]asacombinedcartilage-steel-
soft tissue prosthesis [45]. The individual adaptation of
the“steelprostheses”offerstailoredsolutionsforspecific
demandssuchasinthecaseofmalformationsormalleo-
vestibulopexy.
Gold does have a high specific weight at 19,3 g/cm
3, but
due to the small dimension of a prosthesis in absolute
terms, this does not have a large influence on sound
transmission (at approx. 50 mg, a typical gold TORP
weighs as much as the intact ossicle chain). Due to its
plasticdeformability,itoffersmechanicalbenefitsinintra-
operative adjustment, and also has an inhibitory effect
on the growth of bacteria [46]. However the compatibility
of gold in the middle ear is the subject of controversy:
whilst Pusalkar and Steinbach [47] were able to observe
in a total of 102 patients only two with an extrusion after
3 years, other research groups reported a considerably
higher rate of extrusion of up to 19% [48]. After initially
favourable results [49], [50], gold piston implantations
in otosclerosis surgery were also seen increasingly critic-
ally [51], as material incompatibility with a formation of
repairgranulomasisassumed[6],[52].Today,goldplays
a subordinate role and has been increasingly replaced
by titanium [53].
Titanium has for many years now held a prominentplace
in reconstructive head and neck surgery for the osseo-
integrated anchoring of epitheses in bone, thanks to the
fundamental research work conducted by Branemark
[54] and Tjellström [55]. It is an extremely light (specific
weight4.5g/cm
3)andrigidmaterial.Thehighmechanical
stability with simultaneous body-compatibility is due to
the fact that the surface of pure titanium immediately
forms a fine titanium oxide layer on contact with oxygen
from air or water. This passive, ceramic layer surrounds
the material protectively, makes it resistant to external
influences, and represents the essential interface in bio-
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of endogenous electrolytes on which stability against
acids and alkalis, as well as corrosion resistance, is
based. The material surface area and purity are decisive
for biological quality of the titanium implant. Remnants
from the production process might produce unwanted
reactions on the titanium surface, due to the various
cleaning procedures of different manufacturers. Pure ti-
tanium is ideal for use in the middle ear, and is classified
into grades 1–4, depending upon composition. This
classification takes place according to increasing iron
and oxygen content, with grade 1 containing the lowest
additives. Figure 2a shows a titanium surface (grade 1)
afterpurification.AnMRTwithafieldstrengthof1.5Tesla
does not result in a dislocation or rise in temperature
[56]. Many titanium implants today are permitted up to
7 Tesla, although the proportion of ferromagnetic mater-
ial can be limiting.
Figure 2: Pure titanium surface after purification (a). (Source:
Kurz, Dusslingen). Iritation-free mucosa and sub-mucosa on
the surface of a titanium implant in the middle ear of a rabbit
(84days,Giemsa,288x)(b).(Source:Prof.Dr.med.Schwager,
Fulda).
In the semi-open and partially inflammatory altered im-
plant area of the middle ear, animal trials demonstrated
the complete epithelisation of titanium (Figure 2b). Due
tothelackofmacrophagesandgiantcells,aswellasthe
lack of signs of degradation on the implant [57], [58], ti-
tanium recommended itself from a biological point of
view as ossicle replacement material. Osteoneogenesis
could be registered on the material, however osseointeg-
ration was proven neither in animal experiments [59],
nor on explanted prostheses from the human middle ear
[60]. Even before these animal studies, titanium had
been clinically used as a passive implant in a large num-
berofcaseswithgoodresults[61].Thisgoodbio-accept-
ability was confirmed by a number of authors [62], [63].
The acoustic advantage of titanium implants lies in their
mechanical stiffness combined with low weight which
allows a fine form design [64], [65], [66]. In this way
anatomicallyunfavourablesituations,suchasaprolapsed
facial nerve in the oval niche, are not an obstacle to im-
plantation for the 0.2 mm thin prosthetic shafts. The
design of an open prosthetic plate made possible by the
mechanicalcharacteristicsallowsthevisualisationofthe
prosthetic foot during insertion. Due to the elastic char-
acteristics of titanium, there is also the possibility of a
clipmechanismforastandardisedandsimpleconnection
to existing ossicles [67], [68], [69].
Nitinol is a nickel-titanium alloy which is covered by a
layer of titanium oxide. The particular feature of this ma-
terial consists of its ability to take on a shape imposed
duringmanufactureatatemperatureof45°C.Thisshape
memory has been used in recent years to secure stapes
prostheses to the long process of the incus in order to
avoidthedifficultstepofmanualconnection.Itispossible
thatnewdesignideaswillbedevelopedforfutureossicle
replacement prostheses. Up until now, however, the risk
of distortion due to heat action, for example for the end
of the eyelet at the periosteum of the incus, is not fully
understood; for this reason necroses of the long process
of the incus cannot be ruled out in the future. During the
first postoperative months, no signs of nitinol prosthetic
loosening have yet occurred [70], [71]. However, critical
topicssuchasnickel-inducedallergydevelopment,ferro-
magneticsafetyduringfuturenuclearspinexaminations,
as well as the contradictory results in animal studies on
biocompatibilitymustcontinuetobestudiedexperiment-
ally [72], [73], [74].
As a precious metal with a density of 21.45 g/cm
3, plat-
inum is characterised by extreme resilience to oxidation
and corrosion. Since the introduction of the platinum-
Teflon prosthesis in stapes surgery, it has been widely
used for securing the piston to the long process of the
incus [75]. Necroses are reported in only 0.7% [49], al-
thoughitremainsinconclusivewhethertheseresultsare
due to the material or not. The good acoustic results
continue to be confirmed today [76].
Aluminium oxide ceramic consists of 3–5 µm large co-
rundum crystals which are sintered into a pore-free,
polycrystalline form [77]. After implantation in an animal
model, a delicate coating of mucosa can be evidenced
without indication of foreign body reactions [78]. The
hardness of the material is responsible for the good
acoustic transmission, also, however, for its quality of
breaking quickly. Ceramic prostheseswith diamondburs
can be attached intraoperatively to individual implant
situations[79]. Onlyaftera follow-up periodoffouryears
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functional results noted [80], [81].
2.2.3.2 Bio-tolerant materials
Bio-tolerantmaterialsareinitiallyrecognisedby thebody
as foreign substances; however, a strong capsule soon
forms upon which endogenous proteins attach them-
selves, thus concealing the implant from the immune
system [82]. Well-known examples of bio-tolerant mater-
ialsarethesyntheticswhichwereintroducedbyWullstein
in 1949 with Paladon
® asplaceholderin window surgery
forthetreatmentofotosclerosis[83].In1952heutilised
the material vinyl resin Palavit
® from dental medicine for
the first time [84]. It was, however, not sufficiently com-
patible with the middle ear, and was rejected at an early
stage.
Polyethylenewasalsoinuseasearlyasthe1950sinthe
USA [85]. As a semi-flexible, spongy substance with a
poresizeof30µm,Plastipore
®(highdensitypolyethylene
sponge) is used as ossicle replacement material [86]. At
first there were only histological studies on explanted
prostheses, as animal experiments were not possible
beforeclinicaluse.Theseshowedachronicinflammatory
reaction with accumulations of exogenous giant cells,
macrophages,celldepositsandvacuole-containingcells,
which was also confirmed in later animal studies [87],
[88],[89].Theextrusionrateoftheseprosthesesisgiven
in clinical reports as up to 38% [6]. Due to the unfavour-
able long-term results, the use of Plastipore
® is advised
against [90]. The large number of patients with rejected
prostheses,andthe resultingnecessary follow-up opera-
tions,underlinestheneedforasufficientbiocompatibility
test in animal studies prior to clinical application.
Polytetrafluorethylene (Teflon) is a plastic which has
hydrophobiccharacteristicswithlowsurfaceenergy[91].
These material properties qualify Teflon particularly for
stapes surgery, where Teflon is the longest and most
frequentlyusedmaterial[92],[93].Afterthefirstdescrip-
tion of Shea’s implantation of Teflon into the open oval
window in 1956 [94], numerous publications confirmed
the excellent audiological long-term stable results in the
context of stapes surgery using Teflon pistons [75], [92].
Histopathological post-mortem reconditioning of stapes
prostheses in temporal bones shows that after years,
Teflon is covered by a thin fibrous layer without any signs
of foreign body reaction [95].
Teflon with carbon was used as Proplast
®. It is up to 90%
porous and has an interconnecting pore system
(100–500 µm) [96]. With human explants, multi-nuclear
giant cells containing foreign bodies were found, which
are regarded a foreign body reaction with degradation of
theimplant[97].Duetostrongforeignbodyreactionwith
consecutive rejection in animal studies, pure vitreous
carbon cannot be recommended as an implant material
[98], [99].
FlexH/A
®isacompositeconsistingofhydroxyapatiteand
silastic in equal proportion. With the addition of soft
silastic, treatment with the diamond drill has been con-
siderably improved in comparison to easily splintering
hydroxyapatite. With the many implant variations, the
prosthesis head often consists of hydroxyapatite, whilst
the Flex H/A
® prostheses stem is connected via a flexible
titanium pin. After 3 years, an extrusion rate of approx.
5% was described alongside the excellent audiological
results [100].
HAPEX
® consistsof a compositionof 40% hydroxyapatite
and 60% polyethylene, which should also provided the
simplest surgical workability of the prosthesis shaft. The
prosthesis head of these hybrid prostheses consists of
hydroxyapatite, which provides good middle ear compat-
ibility.Thefunctionalresultsaregood[101],[102];foreign
body reactions with induction of resorption processes
have not been proven [103].
2.2.3.3 Bio-active materials
Bio-active materials are integrated into the organism
without capsule formation and develop a permanent
bond. With inflammatory processes their resorption rate
is raised.
Glass ceramics which are created by melting bio-active
glass consist mainly of SiO2. On contact with surrounding
endogenous substances, a layer of calcium phosphate
forms on the surface from which a connection to the ad-
joiningbonearises.Thebasisforthedevelopmentofbio-
active ceramics such as Bioglass
®, which although bio-
acceptable [104], was quickly degraded in the middle
ear. The bio-active ceramic Macor
® was introduced in
1980. In the middle ear of rabbits, these implants did
exhibit a non-irritable mucosal coating, but with exogen-
ous giant cells in sub-mucosal tissue. Ossification with
thesurroundingareawasfrequentlydescribed,andmade
the material appear to be unsuitable in the long-term
[105].Ceravital
®wasintroducedintoclinicalotologyafter
animalstudieshadshownanon-irritablehealingprocess
[106].Itcannotdissolvecompletelyinaninflamedmiddle
ear, however [107]. Bioverit
® was developed by Beleites
in Jena. It consists of a mica and a vitreous phase. The
mica content determines the fact that this glass ceramic
can be drilled, turned and milled. The phlogopit crystals
are responsible for the easy operative workability using
grinding, and the apatite crystals for bio-acceptance. An-
imal studies were able to show a coating of the implant
with single and multi-layer epithelium. Not with bone,
however [108]. A further advantage of Bioverit
® in the
contaminated middle ear is the inhibited growth of gram
negative bacteria [109].
Hydroxyapatite is a natural component of bone and with
a pore size of 2 µm is used as a ceramic implant, which
explains the fragility and splintering tendency. Animal
studies confirm the good bio-acceptance [110], but with
highbiodegradability[111].Thegoodaudiologicalresults
with a low extrusion rate have been confirmed by several
authors [112], [113].
Glass ionomer cement is produced in an exothermic re-
action brought on by calcium aluminium fluorosilicate
glassandthewaterysolutionofapolyalkenoicacidwhich
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clinical use [15], implants were coated with mucosa
withinashorttimeandassessedasbio-stableandmiddle
ear compatible. It can be processed exactly with a dia-
mond drill without splintering [115]. Glass ionomer ce-
ment was also used in liquid form as a twocomponent
material for the bridging of defects of the long process
of the incus [116]. Due to lethal aluminium intoxication
when using the liquid material with liquor contact, it was
removed from the market for use in the middle ear in
1995 [117].
2.2.4 Which materials are used?
At the present time there are a vast number of the
aforementioned materials for ossicle chain replacement
registered and commercially available. 10 years ago in
theUSA,asurveyonthefrequencyofuseofbiomaterials
revealed that hydroxyapatite was then used 82%, Plasti-
pore
® 59% and titanium 12% of the time [118]. Current
data has shown that in recent years, in Europe at least,
titanium has gone beyond the field of ceramics. Here
titanium is used as a biomaterial in 68% of cases,
hydroxyapatite only in 24% [119]. Plastipore
®, on the
other hand, is only used by a few centres. The delicate,
light yet solid titanium implants are, according to current
knowledge, easier to work with for many otologists than
therelativelyungainlyandvoluminousceramicprostheses
withsimilarmiddleearacceptance,wheretheintra-oper-
ative adjustment requires additional grinding. In a com-
parative clinical study, however, acoustic advantages for
titanium could not be presented as significant [120] as
anumberofotherfactorsinfluencepostoperativehearing.
With the selection of the implant material, individual
preferences and the related experience of individual
surgeons also plays an important role, so that hybrid
prostheses such as HAPEX
® or Flex H/A
® continue to be
used justifiably, based on clinical data.
2.3 Techniques of ossicle chain
reconstruction
2.3.1 Reconstruction with defects of the long
process of the incus
The long process of the incus is most frequently involved
in defects in the ossicle chain [121]. In the past, many
differentmaterialswereusedtotryandbridgethedefect
and reconstruct an intact ossicle chain. Amongst these
wereautogenicbones[122]orboneimplants,adhesives
or cements [116], [123], as well as angle prostheses
madefrommetal[116],morerecentlyalsoequippedwith
a clip mechanism for a stable connection to the stapes
head. From an acoustic point of view, the use of adhe-
sives and cements, if they remain fixed, is a particularly
elegant solution. The sonically rigid connection then
promises excellent acoustic results which are hard to
achieve with cartilage and bone interposition. Cartilage
is too soft and thus only to be recommended as an im-
plant for very small defects, e.g. in the incudostapedial
joint.Bones,e.g.asarectangularimplant,maybeharder,
howeverafixedconnectionishardtoachieve.Onefurther
possibility is the use of cartilage in the sense of a tym-
panoplasty type III, which has a recess for receiving the
long process of the incus, and which is attached directly
to the stapes head. The disadvantage of this reconstruc-
tionwiththeconnectionofthestapestothereartympanic
membrane is the disabling of the functioning tympanic
membrane-malleus complex which corresponds to an
“acoustic short circuit”. In the case of larger defects of
the long process of the incus, the endogenous incus is
reformed and placed as an implant between the stapes
head and the tympanic membrane, or rather the
manubrium of malleus.
2.3.2 Connection to the manubrium of the
malleus
The contactto the manubriumof the malleushas proved
tobeoptimallysuitablebothintemporalbonetrials[124]
and in finite element calculations [125] for transmitting
acoustic energy as efficiently as possible to the im-plant.
The presence of the manubrium of the malleus also rep-
resents an important clinical audiological prognostic
factor for successful ossiculoplasty [9], [10]. A further
advantage of anchoring of an implant at the manubrium
ofthemalleusisbetterstabilisationandhigherprotection
from extrusion. However, bonding should not always be
forced, for example in the case of badly aerated middle
earwithverticalmalleusorwithalargedistancebetween
the manubrium of the malleus and the stapes. The re-
quired inclined angle of the prosthesis carries the post-
operativeriskoftippingoverontothepromontoriumwith
consecutive conductive hearing block. With a tilt of more
than 45° the annular ligament is placed un-der tension
[27],whichdevelopsintoacoustictransmissionloss.New
prostheticformswith a “notch”attempt to combinea flat
titanium prosthesis plate with the manubrium of the
malleus [126] (Figure 3a).
Figure 3: MNP – Malleus Notch Prosthesis partial (a) and CliP
®
partialprosthesistypeDresden(b).(Source:Kurz,Dusslingen).
2.3.3 Connection to the tympanic membrane
In the case of a missing or unusable manubrium of the
malleus,implantsarebroughtintodirectcontactwiththe
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ear. The frequency is plotted as a function of the amplitude of the footplate displacement for prosthetic plates of 1.4 mm, 2.6
mm and 5 mm in size.
tympanic membrane. According to its own FEM analysis,
the size of the contact zone (diameter of the prosthetic
plate) should be approx. 3 mm: any enlargement would
raise the hydraulic amplification factor, but the hard sur-
face increases the reflection of incident sound on the
tympanic membrane, and thus worsens impedance con-
version(Figure4).Withprosthesesmadefromalloplastic
materials, a cartilage covering is usually placed on the
prosthetic plate in order to prevent a protrusion through
the tympanic membrane, although some authors do not
regard this as a necessary step using their titanium im-
plants [127]. The thickness of the cartilage should de-
crease peripherally from the plate, in order to keep the
attachment of the prosthesis to adjoining osseous struc-
tures, such as the auditory canal wall or the lateral
semicircular canal, as small as possible in an open pro-
cedure.LDVmeasurementsinatemporalbonelaboratory
confirm the acoustic superiority of smaller cartilage cov-
erings [128]. For a stable connection between the cartil-
age covering and the prosthetic plate, in the case of the
TTP
®-VARIO prosthesis (Kurz, Dusslingen Germany) a
“monospike” can be cut from the projecting shaft, or the
plate has already been provided with 0.33 mm high
spikes by the manufacturer [129].
2.3.4 Connection to the stapes superstructure
Forasolidanchoringoftheprosthesistothestapes,both
from an acoustic point of view as well as to avoid tilting
on exposure to mechanical stress, the prosthesis should
be individually adapted to the form of the stapes head.
When forming an endogenous residual incus it is there-
fore recommended to drill longitudinally oval (in congru-
ence to the stapes head) into the residual ossicle as
deeplyaspossiblewithadiamonddrillforthepositioning
of the stapes head. With alloplastic implants there are a
numberofdesigntypeswhichestablishcontactinsleeve,
bell or pan shape, or with an elastic clip-mechanism
(Figure 3b). In order to avoid loose contacts and reson-
ance, the prosthesis bell should be attached at 50 mN
onto the stapes head [130]. An absolutely solid contact,
as is achievable, for example, through bony growth or
adhesion,wouldnothoweverbefavourable,astheremov-
al of the prosthesis during a revision operation would
bring the risk of a stapes luxation. A standardised solid,
but at the same time easily resolvable, connection to the
stapessuperstructureallowsfortheclipdesignofatitani-
um prostheses with seven elastic titanium feet (Figure
3b). After optimising the shape and the spring forces in
a temporal bone experiment, there were good clinical
and acoustic results, as well as uncomplicated removal
in the case of revision procedures [68].
Oneimportantfactorfortheacousticqualityisthetension
with which the implants are fitted between the residues
of the chain. Amongst other things, it can vary as to the
prosthesis length, tilt, and also the thickness of the cov-
ering cartilage plate. Experimental investigations of this
factor always suffer from the lack of quantification of the
statement “loose” or “tight” fit. It was therefore possible
to find a better transfer function for “loosely” fitted pros-
theses, particularly in the low frequency region [124]. If
in doubt, however, in clinical use a stable contact with a
somewhat larger prosthesis length should be chosen in
order to ensure postoperative fixed contact of the pros-
thesis through the scarring and the resulting low lateral-
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tightening of the tympanic membrane.
2.3.5 Connection to the stapes footplate
Inthecaseoftheinterpositionofatotalprosthesis(TORP)
as a so-called columella, the secure centring of the foot
of the prosthesis in the middle of the plate is absolutely
vital. Dislocations of the prosthesis, which is only held in
place by water adhesion, are the most common cause of
unsatisfying hearing [131], [132]. Two factors are:
1. The diameter of the foot of the prosthesis should be
small so that if there is a lateral displacement, it does
not come into contact with the bony frame of the oval
window. A thicker or even oval–shaped shaft or shoe in-
creasesthisriskwithoutofferinganyacousticadvantage.
The possible danger of a fracture of the footplate with a
thinnershaftdiameterhasprovedunfoundedintemporal
bone experiments: physiological pressures would also
never be able to fracture the stapes footplate, even with
a shaft diameter of down to 0.2 mm [133].
2.Anumberofsolutionshavebeensuggestedforastable
centring of the foot of the prosthesis, including the con-
troversial perforation of the middle of the footplate with
a wire spike at the foot of the prosthesis [127]. Added
connective tissue, gelatinous sponges or pieces of cartil-
age can surround and stabilise the prosthesis in the oval
niche. A cartilage shoe with central perforation can be
produced simply by punch, and following experimental
testing has also shown clinically exceptional acoustic
results (Figure 5) [134], [135].
Figure 5: Cartilage shoe in the oval window with a centrally
guided titanium total prosthesis.
2.4 Outlook
In recent years, biocompatible but partially degradable
ceramics have universally been pushed into the back-
ground by light-weight and delicate titanium implants.
The connectionof the prosthesishas becomeeasierand
more standardised through the introduction of clip
mechanisms.Combinedprosthesesarebeingdeveloped
for connection to the footplate, where prosthetic anchor-
ing is integrated osteally onto the footplate. In a further
stepwhichrequiresasecondoperation,atotalprosthesis
can be inserted [136].
Protection against atmospheric fluctuations in pressure
should be integrated into future prostheses. With their
straight alignment, these latest types of prosthesis
transmit “unchecked” static ambient pressures [137].
Under consideration here is a ball-and-socket type con-
nection between the prosthetic plate and shaft, or the
integration of a silicon microjoint into the shaft of the
prosthesis.Aswithabirdcolumellatheshaftisdeflected
with atmospheric pressure fluctuation, and the risk of a
trauma of the inner ear with unrestricted acoustic prop-
erties is minimised [138].
3 Active middle ear implants
Conventional air conduction hearing devices inserted in
the auditory canal are the typical method of treatment
withlowormediumsensorineuralandcombinedhearing
loss. Their acceptance is significantly reduced by un-
desired effects:
1. Stigmatisation due to the aesthetically unpleasing
hearing aid
2. Unsatisfactory hearing due to sound distortion and
feedback
3. Occlusionoftheauditorycanal,sometimeswithrecur-
ring inflammation
Conventionalhearingaidsresistanttomoisture,andthus
suitable for bathing and swimming, remain a vision for
the future. However, many of the constraints related to
wearing a hearing aid, such as the occlusion effect and
the problem of feedback, have been reduced due to re-
cent technological advances [139], [140] such as mini-
aturisation,cosmeticallyacceptableaidsandthepossib-
ility of open or semi-open hearing systems. Along with
improved sound quality, this has resulted in higher
wearing comfort and higher acceptance. For severe
hearing loss or steep drops in high frequency, which up
until now have been unsatisfactorily provided for, hybrid
cochlea implants with their electro-acoustic simulation
[141] represent a completely new technology. For active
middleearimplants,theaudiologicalindicationspectrum
has recently been considerably restricted, and is mostly
reduciblewithpuresensorineuralhearinglosstomedical
(auditory canal problems) or cosmetic reasons. A previ-
ously little noticed, but almost exclusive indication for
implantable hearing aids which has long been followed
in temporal bone experiments [142], seems to be devel-
opingforconductiveormixedhearinglossesthroughnew
operating procedures.
3.1 Principle of active middle ear
implants
Middleearimplantswhosefunctiondependsuponextern-
al energy supply are classified as active [143]. A distinc-
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transducer is im-planted) and fully implantable devices,
where a microphone and power supply are implanted.
Other than with conventional air conduction hearing
devices,theenhancedelectricalsignalsarenotconverted
into airborne sound energy, but rather into mechanical
vibrations which are either connected to the anatomical
structure of the sound conduction apparatus (tympanic
membrane or ossicle), or fed directly into the cochlea
without occluding the auditory canal [144]. A key role is
played here by the electromechanic transducer which is
appliedwithcurrentlyapprovedequipmentinelectromag-
netic or piezoelectric functionality [143], [145].
Electromagnetic transducer
The basic principle of an electromagnetic transducer is
the generation of vibrations through a regulated variable
force between an electric coil through which a current
flows, and a magnet [146]. Here the magnet can be loc-
ated either inside or outside the coil.
Piezoelectric transducer
Piezoelectric crystals are able to carry out a relative
change in length with an applied voltage. This character-
istic is reversible, in other words a mechanicalconforma-
tional change (movement), and conversely mechanical
movement results in an electrical voltage [147].
Both systems have their specific advantages and disad-
vantages as electromechanical transducers in active
middle ear implants. The efficiency of electromagnetic
transducerssinksconsiderablyasthedistanceincreases
form the coil and magnet, so that in order to increase
efficiency, both should form a single unit. They have
highermaximumoutputamplitudethanthepiezoelectric
transducers, which can, however, be compensated by
stringing together several piezo crystals. On the other
hand,electromagnetictransducersusemoreenergywith
similaracousticcapacity, which can be disadvantageous
for use in fully implantable systems. Piezoelectric trans-
ducers continue to have advantages due to their low
tendencytodistortion[148],buttheyalsohavedisadvant-
agesduetotheirrigiditywiththerelatedriseinresistance
oftheconductiveapparatusonconnectiontotheossicle.
MRT compatibility cannot at present be expected from
electromagnetic systems.
3.2 Current approved active middle ear
implants
Thehistoryofimplantablehearingdevicesbeganasearly
as 1935, when Wilska suggested placing small magnets
(10 mg) onto the tympanic membrane controlled by a
magnetic field generated by a coil in the outer auditory
canal [149]. Suzuki and Yanagihara [150], [151] were
the first to insert a semi-implantablepiezoelectricdevice
inahumanwithatpresentmorethan10years’long-term
results [152]. Approval for this “rion device E-type” was
atfirstlimitedtouniversityinstitutionsinJapan.Afurther
stage in development was the fully implantable system
TICA
©(TotalImplantableCochlearAmplifier)manufactured
by the Implex company [153] which is also no longer
produced. This piezoelectric system was capable of in-
creasing higher frequencies very effectively. The micro-
phone placed under the skin of the auditory canal led to
feedback, however [154], which required an interruption
of the ossicle chain. In the Soundtec Direct Drive Sys-
tems
© device, a samarium cobalt magnet with a holding
ring was put over the stapes capitulum [155]. It had
reached market maturity in the USA and was advertised
with the low costs of the implant, as well as the simple
ambulatory tympanotomy carried out under local anaes-
thesia to insert the implant. The necessary severing of
theincudostapedialjointandthepositionofthestimulat-
ing coil in the outer auditory canal are unfavourable,
however, and do not constitute any improvement over
conventional hearing aids. This device is no longer pro-
duced although research for the development of a fully
implantable system is being undertaken [156].
Recently,severalconceptsforactivemiddleearimplants,
as well as the possibilities of connection them, are being
presented in numerous experimental and clinical appli-
cations. Due to the brief scope of this paper, reviews are
referredtoinwhichthehistoricaldevelopmentandbasic
principles are comprehensively presented [143], [145].
In the following, only the currentstate of the CE-certified,
and therefore the active middle ear devices approved for
use on the European market, will be described.
3.2.1 VibrantSoundbridge
® (MedEl,Innsbruck,
Austria)
This partially implantable hearing device functions with
electromagnetic transducer technology. The external
components are contained by the audio processor, the
microphone, the battery as well as the transmitter coil
and a magnet. It absorbs the acoustic energy, processes
it and passes it on transcutaneously to the internal com-
ponents. Here it is demodulated and transformed into
vibration energy by the electromagnetic transducer. The
VORP(VibratingOssicularProsthesis)transducerconsists
of a receiver with coil and processor element, as well as
a magnet corresponding to external components. The
processor (demodulator) converts the transcutaneously
conducted signal into one which is adequate for the
electromagnetic transducer. This is then introduced to
the Floating Mass Transducer (FMT) via an electrical
cable. This actuator uses the rebound force of a moving
permanent magnet in a hermetically sealed coil. This
stands still whilst the coil vibrates as an outer casing.
Since the first implantation in 1996, the Vibrant Sound-
bridge
© is the most extensively distributed worldwide,
with more than 3,000 implantations.
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sensorineural hearing loss.
Figure7:ThepartiallyimplantablesystemVibrantSoundbridge
®(MedEl,Innsbruck,Austria).Classicvibroplastywithconnection
to the long process of the incus (a). Alternative connections of the FMT: to the round window (b), laterally on a Bell prosthesis
(c), linearly as a TORP vibroplasty (d) and next to a stapes piston (e) (Source: MedEl, Innsbruck, Austria).
VibrantSoundbridge
®(VSB)insensorineuralhearingloss
As an indication, only pure sensorineural hearing loss
with the indication area represented in Figure 6 was ap-
proved.ThesurgicalapproachresemblestheCI-operation:
transmastoidally the FMT is attached with its titanium
clipto thelongprocessoftheincusvia posteriortympan-
otomy with a special closing forceps (Figure 7a). A trans-
canal access is an option [157]. The attachment of the
FMTtakesplaceparalleltotheverticalaxisofthestapes.
The VORP is set in an appropriately drilled out bone bed.
The audiological indication is mild to moderate hearing
loss with low losses of up to 1 kHz, whereas due to the
better efficiency of the transducer in a higher frequency
range,strongerlossescanbecompensated[158],[159].
The highest auditory threshold gain is between 1 and 2
kHz between 28–37 dB [160], [161], [162], [163] with
good long-term stability [164]. It is not so much the gain
inloudnesswhichisdecisiveforhighpatientsatisfaction,
but rather the clear and undistorted auditory impression
basedparticularlyupongoodhighfrequencyamplification,
which is the weak point of conventional air conduction
hearingdevices.Severalstudiescomparetheaudiological
results between conventional hearing aids and the VSB
[165], [166], [167], [168]. Thus the VSB delivers better
results in speech understanding in quiet and with back-
ground noise than a conventional air conduction hearing
device which uses an identical signal technique from
Siemens [166]. In further studies with conventional
hearing aids from other manufacturers, however, this
superiority could not be confirmed either for speech un-
derstanding in quiet or with background noise. In view of
the operative risks and the potentially associated side-
effects such as haematoma, gustatory disorders, MRT
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failures [160], [168], [169], application at present is to
be recommended only if it is medically necessary [167],
[168].
Vibrant Soundbridge
® in mixed hearing loss
Conductive hearing loss represents a new indication for
implantablehearingdevices,alsocombinedwithaninner
ear disorder, as occurs with an operatively no longer
correctable functional disorder of the middle ear as a
resultof a chronic inflammationof the middle ear or with
malformationsoftheouterandmiddleear.HeretheFMT
isconnectedtothemembraneoftheroundwindow[170],
[171], [172] (Figure 7b). This positioning, however, is not
always unproblematic as considerable anatomical vari-
ationsoftheonlytangentiallyvisibleroundwindowniche
and mucosal folds or scar tissue are present over the
actualmembrane.Fortherequiredlargesurfacecontact
between FMT (2 mm
2) and the generally much smaller
round window membrane (on average 1.4 mm
2 [173]),
the bony lip of the round window niche must always be
drilled. This drilling requires great care without touching
the membrane with the drill, considering the confined,
tilted access through the posterior tympanotomy and the
soundlevelbeingpotentiallydamagingtothemiddleear.
For an improvement of contact to the membrane and to
avoid touching the surrounding bone, coating the FMT
with connective tissue is recommended. These incalcul-
able contact problems, along with the threat of atrophy
of the contact tissue coating with weakening contact,
might explain the large variability in hearing with the
round window application [170], [171], [174].
An integration of the transducer into the physiological
direction of sound, i.e. via the oval window, might avoid
theseproblems.ThroughacombinationofaBelltitanium
prosthesis (Bellvibroplasty) with the FMT, a passive im-
plant is turned into an “active middle ear prosthesis”
(Figure 7c) [175]. The selected lateral fastening of the
FMT to the prosthetic shaft can, however, encourage tilt-
ing of the prosthesis. A linear integration of the FMT in a
titanium column with fastening in a clip mechanism
avoids this disadvantage. This construction is familiar to
otological surgeons as, like a TORP, it is placed on the
footplate and securedthere with a cartilage shoe (Figure
7d) [176]. The first clinical results of this standardised
connection confirm the high amplification level demon-
strated in the previous temporal bone experiment. With
an intact stapes superstructure, attachment with a clip
mechanism is also possible. One further promising indi-
cation area of the VSB is otosclerosis surgery where the
FMT is attached next to a stapes piston on the long pro-
cess of the incus, e.g. in order to rehabilitate associated
perception hearing impairment (Figure 7e) [177], [178].
3.2.2 Middle Ear Transducer
® (MET) (Otologics,
Boulder, USA)
The MET was initially conceived as a semi-implantable
hearing aid [179] which is currently still available on re-
quest,astheCARINA
®offersafullyimplantableavailable
version [180] (Figure 8). It consists of a transducer, a
receiver element, power source (rechargeable battery),
sound processor and microphone. The electromagnetic
transducer is attached to the cortex of the opened
mastoid with at least 3 bone screws via retro-auricular
access, and connected with the body of the incus via
antrotomy, guided by a linking rod (Figure 8a). For this,
a 1 mm deep trough is first formed in the body of the in-
cus to house the rod using a fibre-coupled diode laser
[181]. After installing the transducer, the exact position
of the linking rod to the incus has to be adapted using a
micromanipulator.Theossiclechainmaynotbedisplaced
too much from its central position by the bone-mounted
transducerin order not to causea tensionof the hanging
ligaments, and thus a transmission deficit. The electro-
magnetic transducer element where force on the ossicle
is not based upon the “actio=reactio” principle of an ac-
celerated mass, as is the case with the VSB, but rather
where the reactive power is absorbed by a fixation of the
implant on the mastoid bone, makes effective use of the
energy expended. This will help to achieve somewhat
higher amplification than the VSB, which is why the MET
is particularly suitable for patients with moderate to
severe sensorineural hearing loss with an increase in
auditory threshold of 40 dB between 1–3 kHz [182]. The
subcutaneous microphone is situated behind the auricle
and thus cannot make use of the directivity and amplifi-
cation properties of the outer ear. It has to be placed in
such a way that movement of the adjacent temporal
muscle does not cause any undesirable artefacts. The
advantageofthefullimplantationisthatthepatientsare
able to use it without restriction (e.g. even when swim-
ming).Adisadvantageisthesurgicallyperformedreplace-
ment of the accumulator battery which has a functioning
life guaranteed by the manufacturer of 5 years. With an
average use of 16 hours a day, a daily charge cycle of 60
minutesisrequired.TheMEThasbeenCEapprovedsince
2000, and has been used world-wide in several hundred
patients. The indication limits have now also been ex-
tendedtocombinedandconductivehearingloss.Forthis
purpose, manufacturer offers coupling devices for the
stapes superstructure, the footplate and the membrane
of the round window (Figure 8b–d). Initial operative suc-
cesses in the context of malformations of the ear [183]
as well as in otosclerosis surgery [178] have been repor-
ted.
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®
(Otologics,Boulder,USA).Classicconnectiontotheincusbody
(a). Alternative connections: to the stapes superstructure (b),
footplate (c) and the round window membrane (d). (Source:
Otologics, Boulder, USA).
3.2.3 Esteem
® (Envoy Medical Corporation,
Saint Paul, USA)
This fully implantable device (Figure 9a) has had CE ap-
proval since May 2006. A piezoelectric rod functions as
a microphone and taps the vibrations of the incus body
whereby the tympanic membrane as well as the polar
pattern and amplification function of the outer ear are
used.Thestapesisalsopoweredbyrod-likepiezo-crystal
(Figure 9b). As this construction would not function due
tothefeedbackfromtheossiclechain,aCO2laserisused
tointerruptthecontinuityoftheossiclechainonthelong
process of the incus. The piezoelectric sensory and actu-
atingelementsarefixedinthemastoid,ontheincusbody
and the stapes head using cement. The fixing of the
sensor should not be rigid, but rather an articulated gap
between incus and sensor should pick up system stress
onatmosphericpressurechange.Thepiezoelectricdriver
is firmly cemented at the stapes head. Sensor and driver
are connected to the processor battery element, which
isfoundinaparietalbonebed.Theelectricsignalsofthe
vibrationspickedupbytheincussensorare,afterfiltering
and amplification by the processor, transferred to the
stapes driver. The implanted battery must be surgically
replaced at regular intervals (actual durability according
tothemanufacturer:upto9years).Aswellastheenergy-
savingpiezo-transducer,digitaltechnologyhasalsobeen
ignoredinfavourofanalog,energy-effectivecomponents.
This system in the il-lustrated induction area (Figure 6)
is approved for sensorineural hearing loss. First results
of the phase I study [184] showed functional implants in
3 out of 7 cases after a follow-up period of 10 months.
Compared to conventional hearing devices, the Esteem
®
implant produced worse results after 10 months, in both
sound and speech audiometric results, on consecutive
fallinamplificationpoweroverthefollow-upperiod.More
recentclinicaldatawith improved instrumenttechnology
are unfortunately not available. The obligatory chain de-
structionisbothclinicallyandethicallyquestionable.The
iatrogenicair-bonegapisaddedtosensorineuralhearing
loss resulting in a mixed hearing impairment. Whether in
the case of a failure of individual components (long-term
stability of the cemented contacts, etc.), not yet ad-
equately tested, a conventional hearing device can then
allowthepatientsocialhearingabilityviathesubstantially
increased air conduction threshold, is questionable.
Figure9:ThefullyimplantablesystemEsteem
®(EnvoyMedical,
St.Paul,USA)Implantwithsensorandactuator(a).Positioning
of the implantwith connectionof the sensor to the body of the
incus, and the actuator at the stapes head after interrupting
theossicularchainatthelongprocessoftheincus(b).(Source:
Envoy Medical, St. Paul, USA).
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